Extended Middle East and North Africa: cervical cancer and human papillomavirus: can we make the case for prevention in this "relatively" low prevalence region?

Vaccine. 2013 Dec 30;31 Suppl 6:vii-viii. doi: 10.1016/j.vaccine.2012.05.038.

Author

Muhieddine Seoud¹

Affiliation

¹ Professor and Vice Chairman, Department Obstetrics and Gynecology, Gynecologic Oncology, American University of Beirut, Medical Centre, Hamra District, P.O. Box: 113-6044, Beirut, Lebanon. Electronic address: mike@aub.edu.lb.

PMID: 24331825
DOI: 10.1016/j.vaccine.2012.05.038

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Africa, Northern / epidemiology
Female
Humans
Middle East / epidemiology
Papillomavirus Infections / complications
Papillomavirus Infections / epidemiology
Papillomavirus Infections / prevention & control
Prevalence
Uterine Cervical Neoplasms / epidemiology*
Uterine Cervical Neoplasms / prevention & control*